NABRIVA THERAPEUTICS PLC |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0001 USD | 0.00% |
|
0.00% | +9,900.00% |
| 2023 | Nabriva Therapeutics plc Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 | CI |
| 2023 | Nabriva Therapeutics plc(OTCPK:NBRV.F) dropped from NASDAQ Composite Index | CI |
Quotes 5-day view
Delayed Quote OTC Markets| 2024-05-03 | |
|---|---|
| Last | 0.0001 $ |
| Volume | 666 |
| Change | +∞% |
| Opening | 0.00 |
| High | 0.00 |
| Low | 0.00 |
Performance
| 3 months | -50.00% | ||
| 6 months | -99.98% | ||
| 1 year | -99.99% | ||
| 3 years | -100.00% | ||
| 5 years | -100.00% |
Volumes
marketsDaily volume
666
Estimated daily volume
666
Avg. Volume 20 sessions
1 309
Daily volume ratio
0.51
Avg. Volume 20 sessions USD
0.13
Record volume 1
5 619 564
Record volume 2
4 150 216
Record volume 3
2 476 893
Capital turnover ratio
0.00
Float rotation
0.00
Basic data
Capitalization (USD)
323
Net sales (USD)
36 935 000
Number of employees
39
Sales / Employee (USD)
947 051
Free-Float
99.05 %
Free-Float capitalization (USD)
320
Average Daily Capital Traded
0.04%
Highs and lows
1 week
0.00
0.00
1 month
0.000.00
Current year
0.000.52
1 year
0.002.24
3 years
0.0058.00
5 years
0.00702.25
10 years
0.004 370.00
Indicators
Moving average 20 days
0.03
Moving average 50 days
0.01
Moving average 100 days
0.02
Price spread / (MMA20)
+26,200.00%
Price spread / (MMA50)
+10,500.00%
Price spread / (MMA100)
+16,400.00%
RSI 9 days
46.92
RSI 14 days
47.33
Sector Comparison - Bio Therapeutic Drugs
| Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
|---|---|---|---|---|---|---|
| 0.00% | 0.00% | - | -99.99% | 323 | ||
| +2.07% | +8.36% | +8.96% | +25.57% | 105B | ||
| +0.23% | +0.91% | -1.43% | +15.22% | 104B | ||
| -1.24% | +2.66% | +4.40% | +0.79% | 22.94B | ||
| +0.52% | +6.32% | -12.15% | -14.49% | 22.34B | ||
| +5.91% | +5.45% | -4.36% | -24.53% | 19.25B | ||
| -2.02% | +1.75% | -39.98% | -35.07% | 17.08B | ||
| +0.15% | +5.65% | -10.04% | -35.05% | 16.96B | ||
| +2.32% | +3.80% | +38.61% | +2.03% | 12.63B | ||
| +1.60% | +3.58% | +313.59% | +236.70% | 8.49B | ||
| -1.13% | +0.24% | -24.53% | -32.21% | 8.26B | ||
| -2.76% | +0.96% | +8.93% | +45.26% | 7.84B | ||
| -0.09% | +0.19% | +0.35% | +30.88% | 7.73B | ||
| -4.12% | +3.56% | -52.84% | -70.20% | 7.44B | ||
| +2.18% | +8.63% | +5.03% | +28.33% | 7.17B | ||
| +1.45% | -0.11% | -21.82% | +65.49% | 6.84B | ||
| Average | +0.32% | +3.39% | +14.18% | +8.67% | ||
| Weighted average by Cap. | +0.84% | +4.35% | +5.89% | +12.82% |
Historical data
| Date | Opening | High | Low | End-of-day | Volume |
|---|
Last transactions
488911cb0a2a203a63058a9b.d5ezuRc2vkf1RR-M1QSyui6M_dhLgc0wknaj7C1Q0jA.E6fZ-iB01B2vH0_E-F32wBndr4AY9qNjpRjQvR4TsGAPxYbTbWaTdoU9Rg
| Date | Price | Volume | Daily volume |
|---|---|---|---|
| 09:33:08 am | 0.0001 | 533 | 1,066 |
Monthly variations
Annual change
| 2024 | +9,900.00% | ||
| 2023 | -100.00% | ||
| 2022 | -87.38% | ||
| 2021 | -75.25% | ||
| 2020 | -81.67% | ||
| 2019 | -9.59% | ||
| 2018 | -75.59% | ||
| 2017 | +0.34% | ||
| 2016 | -38.05% | ||
| 2015 | -27.34% |
- Stock Market
- Equities
- NBRVF Stock
- Quotes Nabriva Therapeutics plc
